GnRH (Gonadotropin-Releasing Hormone)

Gonadotropin-releasing hormone (GnRH) is a ten-amino-acid (decapeptide) hormone synthesised and secreted by specialised neurones in the hypothalamus, principally those projecting to the median eminence. Released episodically into the hypothalamo-hypophyseal portal blood, GnRH binds GnRH receptors (GnRHR) on pituitary gonadotroph cells to stimulate the synthesis and release of luteinising hormone (LH) and follicle-stimulating hormone (FSH).

Why it matters in peptide research

The GnRH pulse is the master signal for reproductive endocrinology. Pulse frequency encodes the hormonal message: slower pulses favour FSH release (supporting folliculogenesis and spermatogenesis), while faster pulses favour LH release (supporting ovulation and testosterone production). This frequency-encoding property means that a sustained, non-pulsatile GnRH signal — as seen with long-acting GnRH agonist drugs — paradoxically downregulates GnRHR and suppresses gonadotropin output, the basis of medical castration in prostate cancer and endometriosis treatment.

For peptide researchers studying the HPG axis, understanding GnRH's pulsatile nature is foundational. The upstream KNDy neurone circuit (kisspeptin, neurokinin B, dynorphin) regulates pulse generation, which means peptides that act on this circuit — such as kisspeptin-10 — can either restore physiological pulsatility or override it depending on dose and dosing schedule. This pulse-dependency also explains why peptide interventions aimed at restoring LH secretion must be designed with dosing intervals in mind rather than continuous infusion paradigms.

GnRH signalling also has roles beyond reproduction: GnRH receptors are expressed in the hippocampus, adrenal glands, and immune cells, suggesting broader neuroendocrine and immunomodulatory functions that are actively studied.

Peptides / stacks that act on this

• Kisspeptin-10 — endogenous upstream regulator of GnRH neurones; exogenous kisspeptin-10 stimulates GnRH pulse amplitude, increasing LH and downstream testosterone

Common misconceptions

GnRH agonists and GnRH antagonists both ultimately suppress gonadal steroidogenesis, but through different kinetics. Agonists cause an initial "flare" of LH/FSH before receptor downregulation suppresses output; antagonists block GnRHR immediately with no flare. This distinction is clinically significant and highlights why the pulsatile vs sustained distinction in GnRH signalling has real pharmacological consequences.